ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 160 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $234,574 | +334.5% | 73,998 | +581.2% | 0.00% | +100.0% |
| Q2 2023 | $53,989 | +11008.8% | 10,863 | -85.9% | 0.00% | -90.0% |
| Q4 2022 | $486 | -99.7% | 77,228 | +352.9% | 0.01% | +150.0% |
| Q3 2022 | $184,000 | -88.2% | 17,053 | -90.0% | 0.00% | -89.2% |
| Q1 2022 | $1,560,000 | +45.4% | 171,247 | +138.2% | 0.04% | +105.6% |
| Q4 2021 | $1,073,000 | -58.4% | 71,891 | -27.3% | 0.02% | -63.3% |
| Q2 2021 | $2,580,000 | +743.1% | 98,912 | +716.1% | 0.05% | +444.4% |
| Q4 2020 | $306,000 | -25.7% | 12,120 | +11.0% | 0.01% | -50.0% |
| Q3 2020 | $412,000 | -80.9% | 10,923 | -78.3% | 0.02% | -83.2% |
| Q2 2020 | $2,158,000 | – | 50,399 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
| Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
| TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
| EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
| CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
| Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
| CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
| Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
| Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
| Navalign, LLC | 75,365 | $238,907 | 0.09% |